The Eye Condition AION Diagnosis Can Include NAION Due to Semaglutide Use
(Posted by Tom Lamb at Drug Injury Watch)
This article discusses a lesser-known possible vision side effect for Ozempic, Wegovy, and Rybelsus, diagnosed as anterior
The European Medicines Agency Proposes Streamlined Pathway for the Approval of Biosimilar Medicinal Products in the EU
The European Medicines Agency (EMA) has published a draft Reflection Paper proposing a streamlined pathway for the approval for certain biosimilar medicinal products (biosimilars) in the EU by reducing the clinical data requirements where justified.
Biosimilars are biological medicinal products
Federal District Court Upholds Authority of HHS to Pre-Approve 340B Rebate Programs; HRSA Submits Proposed 340B Rebate Guidance
A federal judge in D.C. recently ruled in favor of the U.S. Health Resources and Services Administration (“HRSA”), an administrative agency under the U.S. Department of Health and Human Services (“HHS”), by finding that drug manufacturers must obtain pre-approval from
Healthcare & Life Sciences Private Equity Deal Tracker: Edgewater Invests in CBCC Global Research
NDIS: Whether responsible for supports after work injury.
Santagada and CEO, National Disability Insurance Agency (Practice and procedure) [2025] ARTA 676 (Link to JADE).
This decision appears to be the first to address the question of whether the NDIS (following legislative amendments in 2024) is responsible for
Who Can Opt Out of Medicare: It’s a Club, and Not Everyone’s Invited
Have you ever dreamed of opting out of Medicare? Of finally breaking free from the labyrinth of CMS regulations, endless audits, pre- and post-payment reviews, and the looming threat of recoupments years after services were rendered? Imagine a world where
Abuse: Stay of proceedings appeal (Victoria).
Trustees of the Christian Brothers v Colbert (a pseudonym) [2025] VSCA 122 (on AUSTLII).
Leave to appeal against a refusal of a stay of proceedings in this matter was granted, but the appeal was dismissed. The decision was a joint
California Senate Passes Bill Regulating Pharmacy Benefit Managers
The California Senate has approved SB 41, a bill now under consideration in the Assembly, that would impose new licensing, transparency, and pricing regulations on pharmacy benefit managers (PBMs). Proponents argue the legislation would curb anti-competitive practices, enhance transparency,
Corners, magasins éphémères, pop-up stores : quel type de contrat conclure afin d’encadrer les mises à disposition temporaires de locaux ?
Qu’il s’agisse d’attirer une nouvelle clientèle, de tester un emplacement, un marché ou un nouveau produit, nombreuses sont les raisons qui poussent les entreprises à rechercher des espaces d’accueil temporaires pour y réaliser leurs projets.
C’est ainsi que fleurissent des